This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centre Hospitalier Universitaire Vaudois. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jacques-Antoine Haefliger: Innovator in Pharmaceutical Formulations
Introduction
Jacques-Antoine Haefliger is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of restenosis. His innovative work has led to the development of a unique pharmaceutical formulation that addresses this critical medical issue.
Latest Patents
Haefliger holds 1 patent for his invention titled "Pharmaceutical formulation for use in the treatment and/or prevention of restenosis." This patent relates to a formulation designed for subjects in need of treatment or prevention of restenosis, along with methods to implement these treatments effectively.
Career Highlights
Throughout his career, Jacques-Antoine Haefliger has worked with esteemed institutions such as the Centre Hospitalier Universitaire Vaudois. His experience in these reputable organizations has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
Haefliger has collaborated with notable colleagues, including Florence Delie and Olivier Jordan. These partnerships have contributed to the advancement of his research and the successful development of his patented formulation.
Conclusion
Jacques-Antoine Haefliger is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact the treatment of restenosis. His contributions to the field exemplify the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile